Japan aims to fast-track review of anti-viral drug remdesivir

Loading

An ampule of Ebola drug Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany. (Reuters) COURTESY BY: https://www.hindustantimes.com/ Japan will fast-track a review of Gilead Sciences Inc’s antiviral drug remdesivir so that it can hopefully be approved for domestic COVID-19 patients a week after the U.S. firm’s filing for such approval, the health minister said on Saturday. Health Minister Katsunobu Kato’s comment comes after remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday. “I’ve heard…

WHO wants invite to China’s probe into virus origins

Loading

UN health agency understood there were a number of investigations under way in China “to better understand the source of the outbreak”, but added that “WHO is not currently involved in the studies in China.”(Reuters) COURTESY BY: https://www.hindustantimes.com/ The World Health Organization said Friday it hoped China would invite it to take part in its investigations into the animal origins of the novel coronavirus. “WHO would be keen to work with international partners and at the invitation of the Chinese government to participate in investigation around the animal origins,” WHO…

Coronavirus trial drug remdesivir’s maker aims for wide distribution: Gilead CEO

Loading

Vials of investigational coronavirus disease (Covid-19) treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, California, US. (via REUTERS) COURTESY BY: https://www.hindustantimes.com/ Gilead Sciences which manufactures remdesivir, is focussed on making the experimental coronavirus drug accessible and affordable to as many people as possible once it is approved, Chief Executive Daniel O’Day said on Friday. Gilead has already said it will donate the first 1.5 million doses of remdesivir and O’Day told NBC’s “Today” show that the company understood its responsibility to make a difference during…

Donald Trump points to Wuhan lab as Covid-19 source, threatens new tariffs as punishment

Loading

COURTESY BY : https://www.hindustantimes.com/ President Donald Trump on Thursday said the United States has intelligence that establishes a virology lab in Wuhan is the source of the pandemic and indicated new tariffs as his administration considers a range of punitive measures such as partly cancelling public debt and allowing victims to sue China. “Yes I have,” Trump told reporters when asked if he has seen intelligence that traces the epidemic’s origin to the Wuhan lab with a high degree of confidence. He did not share any evidence and when asked…

Armed protesters demand end to Covid-19 curbs in US state

Loading

US President Donald Trump holds up a presidential proclamation declaring a “Older Americans Month 2020” during an event about senior citizens and the coronavirus disease (COVID-19) pandemic in the East Room at the White House in Washington.(REUTERS) COURTESY BY: https://www.hindustantimes.com/ Hundred of protestors, some of them armed with guns, swarmed Michigan state’s assembly building in Lansing Thursday demanding removal of stay-at-home Covid-19 restrictions. Michigan is among the hardest hit by the virus with more than 3,700 fatalities till Thursday, and upwards of 41,000 infections. The state’s Democratic governor Gretchen Whitmer has…

US finds tentative cure for Covid-19, hunts chutes for a vaccine

Loading

A lab technician visually inspects a filled vial of investigational coronavirus disease treatment drug remdesivir at a Gilead Sciences facility in La Verne, California, US. (Gilead Sciences Inc/Handout via Reuters) COURTESY BY: https://www.hindustantimes.com/ A sliver of hope ran through a nation ravaged by a new virus and shuttered at home after a top US government scientist announced Wednesday that data from ongoing federal trials demonstrated that an antiviral drug can significantly shorten the duration of the illness and hasten recovery from coronavirus. News reports indicated the US Food and Drug…